Sign in
Active, not recruitingPhase 3

Comparison of an Inhaled Sedation Strategy to an Intravenous Sedation Strategy in Intensive Care Unit Patients Treated With Invasive Mechanical Ventilation

Key facts

Who runs it
University Hospital, Brest
Where
France10 sites in 1 countryChoose a country to see its sites
Status
Active, not recruiting
Phase
Phase 3
People taking part
250 people, planned
Started
6 Aug 2020
Ended
2 Sept 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Propofol + analgesic drug
  • Isoflurane + analgesic drug
Record updated
16 June 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Patient aged 18 and over
  • Patient requiring mechanical ventilation for at least 24 hours
  • The patient requires continuous and immediate sedation for more comfort, safety and to facilitate the administration of survival measures
  • Consent obtained from patient or relative

Who cannot take part

  • Cardiac arrest
  • Stroke; Hearing, visual or aphasia disorders before inclusion making it impossible to take the CAM-ICU; Sedation started more than 24 hours ago; Impairment of cognitive functions and / or dementia; Contraindication to halogenated gases (personal or family history of malignant hyperthermia, acute or chronic neuromuscular disease, hepatocellular insufficiency with PT <30%); Severe acute respiratory distress syndrome (ARDS) (Berlin criteria: PaO2 / FiO2 <100 after ventilatory optimisation)); PaCO2 at inclusion> 50 mmHg after ventilatory optimisation; Patient for whom a procedure of "limitation of active therapies" is envisaged at inclusion; Patient under guardianship or curatorship; Minor patient; Pregnant or breastfeeding woman; Patient not affiliated to the social security scheme
  • Patient hospitalized for the following reasons for admission:
  • State of refractory epilepticus
  • Head trauma

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The objective of the study is to determine the impact on the frequency of occurrence of delirium of an early inhaled sedation strategy (from induction in rapid sequence if intubation in intensive care, or from admission if intubated in pre -hospital) by Isoflurane using an ANACONDA ™ type system, compared to a conventional intravenous sedation strategy.

The 2 groups in the trial

  • Usual sedationExisting treatment, for comparison

    Sedation according to a written, standardized Nurse management protocol using at least one sedative drug (propofol) and one analgesic drug.

    Treatment: Propofol + analgesic drug

  • Inhaled sedationTreatment being tested

    Sedation by inhalation of halogenated gas (Isoflurane) delivered by the Anesthetic-Conserving Device (ACD) system ANACONDA ™ associated with the administration of an analgesic drug.

    Treatment: Isoflurane + analgesic drug

Data and sources

Registry record
Listed on ClinicalTrials.gov and on the EU's official list of trials (CTIS).How to verify a trial in the registry
Official title
Comparison of an Inhaled Sedation Strategy to an Intravenous Sedation Strategy in Intensive Care Unit Patients Treated With Invasive Mechanical Ventilation : INASED Study
Publications
Record updated
16 June 2026